Mefenamic Acid Capsules, USP, 250 mg, 30-count bottle, Rx only, Distributed by Prasco Laboratories, Mason, OH 45040, Manufactured by Halo Pharmaceutical Inc., Whippany, NJ 07981, NDC 66993-070-30
Published January 24, 2018 · Recall initiated: May 24, 2017
Summary
FDA records drug Class III recall D-0219-2018, published January 24, 2018 and initiated May 24, 2017. Recalling firm: Shionogi Inc.; Status: Terminated; Reported quantity: 968 bottles; Lot: Lot#: 7H66200103G, Exp 12/19. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of foreign substance: The recall was initiated due to black particles being observed while performing routine post-release stability testing on Mefenamic acid capsules
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Shionogi Inc.
- Distributor
- U.S.A. Nationwide
- Lot
- Lot#: 7H66200103G, Exp 12/19
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAShiseido Future Solution LX Discovery Set contains SPF 50+ (octinoxate 4.9%, octocrylebe 3.0%, oxybenzone 1.0%January 24, 2018
- FDAePHEDrine Sulfate In 0.9% Sodium Chloride, 5 mg per mL (50 mg per 10 mL), 10 mL Total Volume pre-filledJanuary 24, 2018
- FDAShiseido Future Solution LX Universal Defense SPF 50+ (octinoxate 4.9%, octocrylebe 3.0%, oxybenzone 1.0% andJanuary 24, 2018
- FDAPONSTEL (Mefanamic Acid) USP, 250 mg capsules, 30-count bottles, Rx Only, Manufactured for: Shionogi Inc.July 26, 2017
- FDAMefenamic Acid, 250mg capsules, packaged in 30-count bottles, Rx Only, Distributed by: Prasco LaboratoriesJuly 26, 2017
- FDANisoldipine Extended Release Tablets, 17mg, 100 count bottle, Rx only, Manufactured for: Prasco LaboratoriesJuly 4, 2012
Questions about this recall
Was Mefenamic Acid Capsules, USP, 250 mg, 30-count bottle, Rx only, Distributed by Prasco Laboratories, Mason, OH 45040, Manufactured by Halo Pharmaceutical Inc., Whippany, NJ 07981, NDC 66993-070-30 recalled?
Yes. FDA published recall D-0219-2018 on January 24, 2018. Reported hazard: Presence of foreign substance: The recall was initiated due to black particles being observed while performing routine post-release stability testing on Mefenamic acid capsules
What should I do if I have this product?
Voluntary: Firm initiated · Letter